{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T09:02:08Z","timestamp":1784883728594,"version":"3.55.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Society of Cytopathology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.jasc.2024.08.127","type":"journal-article","created":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T17:38:24Z","timestamp":1723657104000},"page":"389-396","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Evolving concepts in thyroid cytology"],"prefix":"10.1016","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3280-0534","authenticated-orcid":false,"given":"N. Paul","family":"Ohori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jasc.2024.08.127_bib1","series-title":"WHO Classification of Endocrine and Neuroendocrine Tumours","year":"2022"},{"key":"10.1016\/j.jasc.2024.08.127_bib2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s12022-022-09707-3","article-title":"Overview of the 2022 WHO Classification of Thyroid Neoplasms","volume":"33","author":"Baloch","year":"2022","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.jasc.2024.08.127_bib3","article-title":"The 2022 WHO classification of thyroid tumors: novel concepts in nomenclature and grading","volume":"30","author":"Juhlin","year":"2022","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.jasc.2024.08.127_bib4","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/cncy.22634","article-title":"The new endocrine WHO classification: What does this mean for thyroid cytology?","volume":"130","author":"Wong","year":"2022","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2024.08.127_bib5","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s12022-023-09756-2","article-title":"The Impact of the 2022 WHO Classification of Thyroid Neoplasms on Everyday Practice of Cytopathology","volume":"34","author":"Rossi","year":"2023","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.jasc.2024.08.127_bib6","series-title":"The Bethesda system for reporting thyroid cytopathology: definitions, criteria and explanatory notes","author":"Ali","year":"2023"},{"key":"10.1016\/j.jasc.2024.08.127_bib7","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/cen.12875","article-title":"Benign thyroid nodules with RAS mutation grow faster","volume":"84","author":"Puzziello","year":"2016","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.jasc.2024.08.127_bib8","series-title":"AJCC Cancer Staging Manual","author":"Amin","year":"2017"},{"key":"10.1016\/j.jasc.2024.08.127_bib10","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1089\/thy.2017.0572","article-title":"Survival in Differentiated Thyroid Cancer: Comparing the AJCC Cancer Staging Seventh and Eighth Editions","volume":"28","author":"Tam","year":"2018","journal-title":"Thyroid"},{"key":"10.1016\/j.jasc.2024.08.127_bib11","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.mpdhp.2018.02.001","article-title":"The contribution of molecular pathology to the classification of thyroid tumors","volume":"24","author":"Xu","year":"2018","journal-title":"Diagn Histopathol"},{"key":"10.1016\/j.jasc.2024.08.127_bib12","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.cell.2014.09.050","article-title":"Integrated genomic characterization of papillary thyroid carcinoma","volume":"159","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.jasc.2024.08.127_bib13","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3390\/jmp2020014","article-title":"Molecular Tests for Risk-Stratifying Cytologically Indeterminate Thyroid Nodules: An Overview of Commercially Available Testing Platforms in the United States","volume":"2","author":"Nishino","year":"2021","journal-title":"J Mol Pathol"},{"key":"10.1016\/j.jasc.2024.08.127_bib14","series-title":"Thyroid Fine Needle Aspiration Cytology Molecular Testing in the USA. In Thyroid FNA Cytology: Differential Diagnosis and Pitfalls","year":"2023"},{"key":"10.1016\/j.jasc.2024.08.127_bib15","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1001\/jamaoncol.2020.5935","article-title":"Effectiveness of Molecular Testing Techniques for Diagnosis of Indeterminate Thyroid Nodules: A Randomized Clinical Trial","volume":"7","author":"Livhits","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jasc.2024.08.127_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.649522","article-title":"Thyroseq v3, Afirma GSC, and microRNA Panels Versus Previous Molecular Tests in the Preoperative Diagnosis of Indeterminate Thyroid Nodules: A Systematic Review and Meta-Analysis","volume":"12","author":"Silaghi","year":"2021","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.jasc.2024.08.127_bib17","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jamcollsurg.2018.12.002","article-title":"Is Frozen-Section Analysis During Thyroid Operation Useful in the Era of Molecular Testing?","volume":"228","author":"Mallick","year":"2019","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.jasc.2024.08.127_bib18","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1111\/coa.13766","article-title":"Utility of intraoperative frozen sections of thyroid tissue in the age of molecular testing","volume":"46","author":"Marshall","year":"2021","journal-title":"Clin Otolarngol"},{"issue":"Suppl 2","key":"10.1016\/j.jasc.2024.08.127_bib19","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.21037\/gs.2019.04.07","article-title":"Role of frozen section in the surgical management of indeterminate thyroid nodules","volume":"8","author":"Najah","year":"2019","journal-title":"Gland Surg"},{"key":"10.1016\/j.jasc.2024.08.127_bib20","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s12022-018-9519-6","article-title":"Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features in Asian Practice: Perspectives for Surgical Pathology and Cytopathology","volume":"29","author":"Bychkov","year":"2018","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.jasc.2024.08.127_bib21","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.21037\/gs-20-430","article-title":"Prevalence of BRAF(V600E) mutation in Asian series of papillary thyroid carcinoma-a contemporary systematic review","volume":"9","author":"Rashid","year":"2020","journal-title":"Gland Surg"},{"key":"10.1016\/j.jasc.2024.08.127_bib22","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/cncy.22692","article-title":"Thyroid FNA cytology: The Eastern versus Western perspectives","volume":"131","author":"Hirokawa","year":"2023","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2024.08.127_bib23","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/cncy.22700","article-title":"Less is more meets do more with less: Exploring differences in thyroid FNA molecular testing between Asian and Western practices","volume":"131","author":"Nishino","year":"2023","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2024.08.127_bib24","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s11154-023-09842-0","article-title":"Molecular testing for thyroid nodules: Where are we now?","volume":"25","author":"Ferraz","year":"2024","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.jasc.2024.08.127_bib25","doi-asserted-by":"crossref","first-page":"48","DOI":"10.21037\/cco-23-49","article-title":"Could a novel category of molecular testing be emerging?","volume":"12","author":"Ferraz","year":"2023","journal-title":"Chin Clin Oncol"},{"key":"10.1016\/j.jasc.2024.08.127_bib26","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/MED.0000000000000754","article-title":"Differences in the management of thyroid nodules in children and adolescents as compared to adults","volume":"29","author":"Goldfarb","year":"2022","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.jasc.2024.08.127_bib27","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.3390\/cancers15072039","article-title":"The Complex Cyto-Molecular Landscape of Thyroid Nodules in Pediatrics","volume":"15","author":"Seminati","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.jasc.2024.08.127_bib28","doi-asserted-by":"crossref","first-page":"723","DOI":"10.3390\/genes10090723","article-title":"Thyroid Cancer in the Pediatric Population","volume":"10","author":"Paulson","year":"2019","journal-title":"Genes"},{"key":"10.1016\/j.jasc.2024.08.127_bib29","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1089\/thy.2018.0728","article-title":"Differences in Thyroid Nodule Cytology and Malignancy Risk Between Children and Adult","volume":"29","author":"Cherella","year":"2019","journal-title":"Thyroid"},{"key":"10.1016\/j.jasc.2024.08.127_bib30","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/cncy.22543","article-title":"Improving risk assessment in indeterminate pediatric thyroid FNA biopsies","volume":"130","author":"Krane","year":"2022","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2024.08.127_bib31","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.suc.2024.02.004","article-title":"The Role of Molecular Markers in Thyroid Cancer\u00a0Diagnostics and Treatment","volume":"104","author":"Sada","year":"2024","journal-title":"Surg Clin North Am"},{"key":"10.1016\/j.jasc.2024.08.127_bib32","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/cncy.22787","article-title":"Challenging the concept of \"risk of malignancy\" in cytology","volume":"132","author":"Nikas","year":"2024","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2024.08.127_bib33","article-title":"Reducing the Number of Unnecessary Thyroid Nodule Biopsies With the American College of Radiology (ACR) Thyroid Imaging Reporting and Data System (TI-RADS)","volume":"14","author":"Abou Shaar","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.jasc.2024.08.127_bib34","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1148\/radiol.2018172572","article-title":"Reduction in Thyroid Nodule Biopsies and Improved Accuracy with American College of Radiology Thyroid Imaging Reporting and Data System","volume":"287","author":"Hoang","year":"2018","journal-title":"Radiology"},{"key":"10.1016\/j.jasc.2024.08.127_bib35","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1089\/thy.2023.0651","article-title":"Does the Adoption of Molecular Testing Cause Decreased Thyroidectomy Rates in a National Cohort? A Quasiexperimental Study of High-Versus Low-Adoption States","volume":"34","author":"Huang","year":"2024","journal-title":"Thyroid"},{"key":"10.1016\/j.jasc.2024.08.127_bib36","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/cncy.22617","article-title":"Probability of malignancy as determined by ThyroSeq v3 genomic classifier varies according to the subtype of atypia","volume":"130","author":"Gajzer","year":"2022","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2024.08.127_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"key":"10.1016\/j.jasc.2024.08.127_bib38","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1002\/cncr.29934","article-title":"Prognostic effects of TERT promoter mutations are enhanced by coexistence with BRAF or RAS mutations and strengthen the risk prediction by the ATA or TNM staging system in differentiated thyroid cancer patients","volume":"122","author":"Song","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.jasc.2024.08.127_bib39","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1002\/cncr.33421","article-title":"Risk assessment for distant metastasis in differentiated thyroid cancer using molecular profiling: A matched case-control study","volume":"127","author":"Yip","year":"2021","journal-title":"Cancer"},{"key":"10.1016\/j.jasc.2024.08.127_bib40","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.surg.2022.05.048","article-title":"Association of comprehensive thyroid cancer molecular profiling with tumor phenotype and cancer-specific outcomes","volume":"173","author":"Liu","year":"2023","journal-title":"Surgery"},{"key":"10.1016\/j.jasc.2024.08.127_bib41","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jasc.2021.10.001","article-title":"Molecular testing results as a quality metric for evaluating cytopathologists' utilization of the atypia of undetermined significance category for thyroid nodule fine-needle aspirations","volume":"11","author":"VanderLaan","year":"2022","journal-title":"J Am Soc Cytopathol"},{"key":"10.1016\/j.jasc.2024.08.127_bib42","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/cncy.22772","article-title":"Molecular-derived risk of malignancy and the related positive call rate of indeterminate thyroid cytology diagnoses as quality metrics for individual cytopathologists","volume":"132","author":"Ohori","year":"2024","journal-title":"Cancer Cytopathol"}],"container-title":["Journal of the American Society of Cytopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213294524001893?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213294524001893?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T13:15:13Z","timestamp":1731590113000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213294524001893"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S2213294524001893"],"URL":"https:\/\/doi.org\/10.1016\/j.jasc.2024.08.127","relation":{},"ISSN":["2213-2945"],"issn-type":[{"value":"2213-2945","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evolving concepts in thyroid cytology","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Society of Cytopathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jasc.2024.08.127","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Society of Cytopathology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}